Back to results
US 2014/0193803 A1Published application
Methods, compositions, and kits for determining hepatitus a virus
AssigneeGrifols Therapeutics Inc.
InventorsDanuta Wronska, Brett Buno, Stefan Burde
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions, methods, and kits for determining the presence or absence of HAV in a sample.
Claims9
An isolated nucleic acid molecule comprising a nucleotide sequence, or a complement thereof, as set forth in:
- (SEQ ID NO:
- 1)
- 5′-GCG CCC GGC GGG GTC AAC TCC AT-3′;
- (SEQ ID NO:
- 2)
- 5′-AGC CAA GTT AAC ACT GCA AGG-3′;
- or
- (SEQ ID NO:
- 3)
- 5′-TTA GCA TGG AGC TGT AGG AGT CTA AAT TGG GG-3′.
7 more elements
A composition comprising a pair of oligonucleotide primers comprising a forward primer having a sequence as set forth in SEQ ID NO:
- l and a reverse primer having a sequence as set forth in SEQ ID NO:2, wherein the pair of primers are capable of annealing to a target sequence under a PCR condition to amplify the target sequence.
A method for amplifying a target sequence, the method comprising:
- performing a PCR with the target sequence as template, wherein performing comprises providing the PCR with a forward primer comprising the sequence as set forth in SEQ ID NO:
- l and a reverse primer comprising the sequence as set forth in SEQ ID NO:2.
Dependencies are inferred from the claim text.